Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 04/10/2026 | CALL | $57.00 | 161 | +158 | +5,266.67% |
| 04/17/2026 | CALL | $53.00 | 83 | +83 | |
| 03/27/2026 | CALL | $55.00 | 84 | +55 | +189.66% |
| 11/20/2026 | CALL | $55.00 | 52 | +52 | |
| 03/27/2026 | CALL | $54.00 | 53 | +37 | +231.25% |
| 11/20/2026 | PUT | $35.00 | 30 | +30 | |
| 11/20/2026 | PUT | $40.00 | 0 | -1 | -100.00% |
| 04/02/2026 | PUT | $54.00 | 15 | -3 | -16.67% |
| 03/27/2026 | CALL | $63.00 | 80 | -4 | -4.76% |
| 06/18/2026 | CALL | $50.00 | 445 | -5 | -1.11% |
| 04/24/2026 | CALL | $53.00 | 11 | -5 | -31.25% |
| 11/20/2026 | CALL | $65.00 | 9 | -7 | -43.75% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Dodge & Cox Stock Fund | 2.22% | 45.46M | 1.57B |
| Dodge & Cox Balanced Fund | 0.29% | 5.99M | 206.79M |
| Price (T.Rowe) International Value Equity Fund | 0.16% | 3.28M | 113.2M |
| Vanguard/Primecap Fund | 0.15% | 3.01M | 103.97M |
| Price (T.Rowe) International Value Equity Trust | 0.14% | 2.86M | 98.7M |
| Fidelity Series Large Cap Stock Fund | 0.14% | 2.84M | 97.98M |
| Price (T.Rowe) Overseas Stock Fund | 0.13% | 2.64M | 91.02M |
| American Mutual Fund Inc | 0.08% | 1.74M | 59.98M |
| Fidelity Growth & Income Portfolio | 0.08% | 1.6M | 55.17M |
| Vanguard/Windsor II | 0.08% | 1.57M | 54.09M |
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
03/16 07:19 am
Benzinga
Read moreBIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
03/16 06:00 am
GlobeNewswire Inc.
Read moreFDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults
03/13 12:33 pm
Benzinga
Read moreHerpes Zoster Market Poised for Robust Growth During the Forecast Period (2026–2036) Driven by Rising Incidence and Vaccine Adoption | DelveInsight
03/09 01:00 pm
GlobeNewswire Inc.
Read moreInfanrix and Infanrix-hexa Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/09 10:58 am
GlobeNewswire Inc.
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read moreDeal Dispatch: Funko For Sale? Caesars Casino Weighs Offers, iPic Bankrupt
02/27 05:05 pm
Benzinga
Read moreGSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play
02/25 08:22 am
Benzinga
Read more35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
02/25 03:00 am
Benzinga
Read moreAnti-snoring Devices Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations and Launches, Sustainability Goals, Revenue Insights
02/24 08:00 am
GlobeNewswire Inc.
Read moreSexual Health Supplement Market Report 2026-2035: Market to Reach $5.31 Billion by 2030, Driven by Biotechnology Innovation, Transparency in Ingredient Traceability and Gender-Specific Expansion
02/20 06:49 am
GlobeNewswire Inc.
Read moreEpstein Scandal Spreads In Europe, Fueling UK Political Crisis And Gilt Market Shock
02/19 10:49 am
Benzinga
Read moreMerck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use
02/19 08:56 am
Benzinga
Read moreEurope Clears GSK's New Twice-Yearly Asthma Treatment
02/17 07:31 am
Benzinga
Read moreUterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
02/16 09:00 am
GlobeNewswire Inc.
Read moreHepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally
02/11 05:00 am
GlobeNewswire Inc.
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
02/05 04:57 am
GlobeNewswire Inc.
Read moreGSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike
02/04 09:12 am
Benzinga
Read moreWave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path
02/02 03:16 pm
Benzinga
Read moreMedicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
01/28 06:51 am
Benzinga
Read moreAtopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
01/27 11:00 am
GlobeNewswire Inc.
Read moreTranspire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
01/27 08:00 am
GlobeNewswire Inc.
Read morePostpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
01/22 12:00 pm
GlobeNewswire Inc.
Read moreHigh Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
01/21 12:00 pm
GlobeNewswire Inc.
Read moreWhy Rapt Therapeutics Stock Soared Today
01/20 06:10 pm
The Motley Fool
Read more$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)
01/20 03:34 pm
Benzinga
Read moreForbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
01/20 03:13 pm
Benzinga
Read moreGSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough
01/20 06:54 am
Benzinga
Read moreSystemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
01/13 02:00 pm
GlobeNewswire Inc.
Read moreAnaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
01/08 07:00 pm
GlobeNewswire Inc.
Read moreGSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies
01/07 12:48 pm
Benzinga
Read moreSitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications
01/06 08:00 am
GlobeNewswire Inc.
Read moreDrugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
12/31 09:59 am
Benzinga
Read moreEvaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
12/19 01:43 pm
Benzinga
Read moreFDA Approves GSK's Drug, Targets Severe Asthma With Two Doses Per Year
12/17 10:04 am
Benzinga
Read moreGSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients
12/12 12:12 pm
Benzinga
Read moreOxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
12/10 03:00 am
GlobeNewswire Inc.
Read moreAstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report
12/03 01:24 pm
Benzinga
Read moreSpero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/28 09:00 am
GlobeNewswire Inc.
Read moreAsthma and COPD Medicines Market Size to Lead USD 19.32 Bn by 2035
11/26 12:00 pm
GlobeNewswire Inc.
Read moreChronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
11/24 02:00 pm
GlobeNewswire Inc.
Read moreGSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties
11/21 09:48 am
Benzinga
Read moreAnaptys Initiates Litigation Against Tesaro, a GSK Subsidiary
11/21 04:50 am
GlobeNewswire Inc.
Read moreSCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
11/19 08:00 am
GlobeNewswire Inc.
Read moreIMU Biosciences announces formation of Scientific Advisory Board
11/13 04:00 am
GlobeNewswire Inc.
Read more